AI assistant
Telix Pharmaceuticals Ltd — Director's Dealing 2017
Nov 14, 2017
31324_rns_2017-11-14_8f1dbd5a-2f35-4e7b-9f12-0100d51e8d5e.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3X Initial Director’s Interest Notice
Rule 3.19A.1
Appendix 3X
Initial Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.
Name of entity Telix Pharmaceuticals Limited ABN 85 616 620 369
We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Mark Alexander Nelson |
|---|---|
| Date of appointment | 17 September 2017 |
Part 1 - Director’s relevant interests in securities of which the director is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
990,000 unlisted share options with an exercise price of $0.85 per option and an expiry date of 14 October 2021, granted subsequent to shareholder approval at the EGM held 13 October 2017.
- See chapter 19 for defined terms.
Appendix 3X Page 1
11/3/2002
Appendix 3X Initial Director’s Interest Notice
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest. MAN Holdings Pty Ltd, as Trustee for The Nelson Hybrid Trust, of which Mark Nelson is a director and shareholder. |
Number & class of Securities 2,238,750 fully paid ordinary shares, of which 770,000 shares were acquired in the Initial Public Offering of the Company at a price of $0.65 per share. |
|---|---|
Part 3 – Director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | Not applicable |
|---|---|
| Nature of interest | |
| Name of registered holder (if issued securities) |
|
| No. and class of securities to which interest relates |
- See chapter 19 for defined terms.
Appendix 3X Page 2
11/3/2002